English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.
Tag: Tisch Cancer Institute
Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology.
NIH Awards Mount Sinai Researchers $12 Million to Personalize Sickle Cell Treatment
The Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.
Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research
Nina Bhardwaj, MD, PhD, Director of Immunotherapy at The Tisch Cancer Institute at Mount Sinai, has received the 2022 Lifetime Achievement in Cancer Research award from the American Association of Indian Scientists in Cancer Research (AAISCR).
Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York
The Mount Sinai Health System announced today a game-changing $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center.
Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD
Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.
Mount Sinai identifies the causes of racial disparity in prostate cancer in a multi-institutional study
MEDIA ADVISORY Senior Author: Ash Tewari, MBBS, MCh, Professor and System Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Prostate Cancer…
$10 Million Gift to Open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai
With highly trained specialists skilled in caring for different types of melanoma, patients at the Waldman Melanoma and Skin Center will have access to the newest diagnostics and therapies such as Canfield Vectra180 – a 3D whole body imaging system that captures nearly the entire skin surface in macro quality resolution, and will be able to capture early skin cancer lesions; Nevisense—a safe diagnostic support tool utilizing Electrical Impedence Spectroscopy (EIS) which is applied as a harmless electrical signal to the skin; Vivascope 1500—a non-invasive confocal imaging system which offers a non-invasive way to image the skin to the superficial collagen layers; and innovative technologies which non-invasively collects skin cells through adhesive patches rather than a scalpel to diagnose atypical pigmented lesions (or moles) at high risk for melanoma.
Celebration of the 10th Anniversary of the Dubin Breast Center Raises $2.3 Million
The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System celebrated its 10th anniversary during its annual gala on Monday, December 7, 2020. The evening honored Eva Andersson-Dubin, MD, founder of the Center and a Mount Sinai trustee, and Elisa Port, MD, FACS, the Center’s Director and Chief of Breast Surgery for the Mount Sinai Health System, and raised more than $2.3 million to benefit the Dubin Breast Center. The center is part of The Tisch Cancer Institute, a National Cancer Institute-designated cancer center.